Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Regeneron (REGN)
NASDAQ:REGN
Regeneron (REGN) Stock Price & Analysis
3,667 Followers
REGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$538.01 - $837.55
Previous Close$746.52
Volume536.62K
Average Volume (3M)567.62K
Market Cap
$81.89B
Enterprise Value$75.63B
Total Cash (Recent Filing)$8.96B
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)20.3
Beta0.74
Next Earnings
Aug 03, 2023EPS Estimate
$10.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)36.81
Shares Outstanding109,710,254
10 Day Avg. Volume535,060
30 Day Avg. Volume567,621
Standard Deviation0.09
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)3.60
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)14.80
P/FCF Ratio14.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.11
Enterprise Value/Gross Profit7.30
Enterprise Value/Ebitda14.87
Forecast
1Y Price Target
$897.75Price Target Upside20.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
Regeneron News
Press ReleasesRegeneron Announces Investor Conference Presentations
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
REGN FAQ
What was Regeneron’s price range in the past 12 months?
Regeneron lowest stock price was $538.01 and its highest was $837.55 in the past 12 months.
What is Regeneron’s market cap?
Currently, no data Available
When is Regeneron’s upcoming earnings report date?
Regeneron’s upcoming earnings report date is Aug 03, 2023 which is in 54 days.
How were Regeneron’s earnings last quarter?
Regeneron released its earnings results on May 04, 2023. The company reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.52 by $0.57.
Is Regeneron overvalued?
According to Wall Street analysts Regeneron’s price is currently Undervalued.
Does Regeneron pay dividends?
Regeneron does not currently pay dividends.
What is Regeneron’s EPS estimate?
Regeneron’s EPS estimate is $10.29.
How many shares outstanding does Regeneron have?
Regeneron has 107,892,105 shares outstanding.
What happened to Regeneron’s price movement after its last earnings report?
Regeneron reported an EPS of $10.09 in its last earnings report, beating expectations of $9.52. Following the earnings report the stock price went down -6.137%.
Which hedge fund is a major shareholder of Regeneron?
Among the largest hedge funds holding Regeneron’s share is Dodge & Cox. It holds Regeneron’s shares valued at 2B.
---
Regeneron Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$897.75 (20.26% Upside)
$897.75 (20.26% Upside)
Blogger Sentiment
Bullish
REGN Sentiment 78%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 192.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days <0.1%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
29.72%
12-Months-Change
Fundamentals
Return on Equity
19.27%
Trailing 12-Months
Asset Growth
14.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Regeneron
Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, manufactures, and commercializes medicines for the treatment of various medical conditions. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.
---
Top 5 ETFs holding REGN
Vanguard S&P 500 ETF
$2.02B
Invesco QQQ Trust
$1.07B
SPDR S&P 500 ETF Trust
$901.57M
SPDR S&P 500 ETF Trust CDI
$901.57M
iShares Core S&P 500 ETF
$714.19M
Up to five ETFs with an Outperform Smart Score that hold REGN. The ETFs are listed according to market value of REGN within the ETF
---
---